α7 nAchRs |
Enhancement of LTP in the hippocampus and in the amygdala |
[46,47] |
3xTg-AD mouse model |
Reduction in α7 nAchRs levels in an age-dependent manner |
[49] |
Blockade of mAchR signaling by an antagonist in rats |
Impairment in the acquisition and consolidation of contextual fear conditioning |
[51] |
Muscarinic agonist against M1 mAchRs in a 3xTg-AD mouse model |
Decrease in β-amyloid plaques accumulation, decrease in tau hyperphosphorylation, improvement in cholinergic activity in the cortex and the hippocampus and improved some cognitive functions |
[54] |
Knockout of M1 and M4 mAchRs in mice |
Impacted hippocampal circuitry and hippocampal release of Ach |
[57,58] |
Lack of M1 AchR in mouse PFC |
Impairment of cholinergic signaling in pyramidal neurons and cue detection deficits |
[59] |
M2 AchR knockout mice |
Deficit in specific learning and memory tests |
[62] |